Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 127   

Articles published

GSK 1,493.59 +64.59 (4.52%)
price chart
Are GlaxoSmithKline plc, Indivior plc and Alliance Pharma plc buys ahead of a ...
One healthcare company with huge appeal is GlaxoSmithKline (LSE: GSK). Not only are its returns less positively correlated with those of the wider index, the company also offers significant diversity and growth potential.
There has never been a better time to buy GlaxoSmithKline plc, Persimmon plc ...
If you are investing in shares, what do you look for? Well, I would say a key component is growth: increasing revenues and increasing earnings.
Why GlaxoSmithKline plc, BAE Systems plc & Imperial Brands plc are top ...
A whole host of FTSE 100 companies have cut their dividends over the past year, reminding investors once again that even blue-chip businesses can't guarantee their payouts.
3 top long-term ISA holdings: GlaxoSmithKline plc, Unilever plc and City of ...
Unlike GlaxoSmithKline and Unilever, this isn't an individual stock, but an investment trust containing a portfolio of around 115 stocks.
Summary of Analysts Rating: Celgene Corporation (NASDAQ:CELG ...
GlaxoSmithKline PLC (NYSE:GSK) after beginning at $41.78, closed at $41.65 by building up +0.39% in recent trading session.
Why GlaxoSmithKline plc and BTG plc are the perfect prescription for growth ...
Blue chip drugs giant GlaxoSmithKline had something to cheer about last week when it announced positive results from the Salford lung study for the company's Relvar Ellipta treatment for COPD (chronic obstructive pulmonary disease).
GlaxoSmithKline PLC (NYSE:GSK) Analyst Rating Consensus
GlaxoSmithKline PLC (NYSE:GSK) has received a short term rating of buy from experts at Zacks with a rank of 2. The stock has been rated an average of 2.6 by 5 Brokerage Firm.
GlaxoSmithKline plc's (GSK) "Buy" Rating Reiterated at Bank of ...  Community Financial News
Recently Issued Stock Ratings For GlaxoSmithKline PLC (NYSE:GSK)  Fiscal Standard
HC Stocks in Hub: GlaxoSmithKline plc (ADR) (NYSE:GSK), Sarepta Therapeutics ...
Shares of GlaxoSmithKline plc (ADR) (NYSE:GSK) ended Thursday session in green amid volatile trading. The shares closed up +0.81 points or 1.94% at $42.56 with 3.26 million shares getting traded.
GlaxoSmithKline plc 6.2% Potential Upside Indicated by Jefferies International
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK has had its stock rating noted as 'Retains' with the recommendation being set at 'HOLD' today by analysts at Jefferies International.
GlaxoSmithKline plc (GSK) Stock Rating Reaffirmed by BNP Paribas  Let Me Know About This
GlaxoSmithKline plc (GSK) Rating Reiterated by Jefferies Group  The Cerbat Gem
GlaxoSmithKline PLC (NYSE:GSK) To Accelerate Filing For COPD Combo Treatment
GlaxoSmithKline PLC (NYSE:GSK) has come up with a plan that will enable it to file for approval of its triple-combo drug for COPD patients sooner than earlier anticipated.
Earnings in Focus: GlaxoSmithKline plc (GSK)  CWRU Observer